Additionally, the effectiveness of combined treatment with chemotherapy and TKIs for patients with the RCSD1-ABL1 fusion and other genetic lesions associated with Ph-like ALL will have to be explored through large multicenter clinical trials. Here, RCSD1 is linked to acute lymphoblastic leukemia.